Are gastric bands safe? It is one of the most common questions asked by people considering weight-loss surgery in the UK. Gastric banding has a well-established safety record when performed by experienced teams in regulated specialist centres, but long-term evidence highlights important risks, including high rates of device-related complications and reoperation. This article explains how the procedure works, what the clinical evidence shows, who qualifies under NHS criteria, and what alternatives are available — helping you make a fully informed decision alongside your surgical team.

How Gastric Band Surgery Works in the UK

Gastric band surgery (LAGB) places an adjustable silicone band around the upper stomach to restrict food intake, performed laparoscopically under general anaesthetic with most patients discharged within one to two days.

Have any more questions about this? Message our pharmaceutical team to get more info →

Gastric band surgery, formally known as laparoscopic adjustable gastric banding (LAGB), is a form of bariatric (weight-loss) surgery performed under general anaesthetic. A silicone band is placed around the upper portion of the stomach, creating a small pouch above the band. This restricts the amount of food a person can comfortably eat at one time, promoting a feeling of fullness with smaller portions.

The band is connected via a thin tube to a small port placed just beneath the skin, usually near the abdomen. After surgery, a clinician can adjust the tightness of the band by injecting saline through this port — a process known as a 'fill'. Tightening the band reduces the opening between the upper pouch and the rest of the stomach, slowing the passage of food further. Loosening it can relieve discomfort or address complications. Band adjustments are typically carried out at regular intervals in the months following surgery and form part of ongoing MDT follow-up, which also includes dietetic and behavioural support.

Unlike gastric bypass or sleeve gastrectomy, the gastric band does not involve cutting or permanently altering the stomach or digestive tract. It is sometimes described as removable — the band can be taken out if necessary — but removal is not always straightforward. It may involve complex surgery, and there is a risk of scarring; some patients subsequently require revision or conversion to another bariatric procedure, and outcomes after removal are variable.

Surgery is performed laparoscopically (keyhole), meaning smaller incisions, reduced recovery time, and lower risk of wound complications compared with open surgery. Most patients are discharged within one to two days, though this varies by individual health status, comorbidities, and centre. Return to light activities typically occurs within one to two weeks, but recovery timelines differ between patients and should be discussed with the surgical team in advance. Further information on the procedure is available on the NHS website and through the British Obesity and Metabolic Surgery Society (BOMSS) patient information resources.

What the Evidence Says About Gastric Band Safety

Gastric bands carry a low perioperative mortality risk in regulated centres, but long-term data show substantially higher reoperation and device complication rates than sleeve gastrectomy or bypass, driving a significant decline in NHS use.

The overall safety profile of gastric band surgery is well-established, with decades of clinical data available. When performed by an experienced bariatric surgical team in a CQC-regulated specialist bariatric centre with MDT expertise and participation in the National Bariatric Surgery Registry (NBSR), the procedure carries a relatively low perioperative mortality risk. UK registry data (NBSR) and the Getting It Right First Time (GIRFT) bariatric surgery national report provide the most reliable current figures for perioperative mortality and complication rates; patients should ask their surgical team for up-to-date centre-specific and national data when making their decision.

However, long-term evidence has raised important questions about the durability and effectiveness of gastric banding compared with other bariatric procedures. Data from the NBSR and studies referenced by NICE indicate that gastric bands are associated with higher rates of reoperation and device-related complications over time compared with sleeve gastrectomy or gastric bypass. Band removal or revision rates in longer-term follow-up are substantial, and this has contributed to a significant decline in the number of gastric band procedures performed on the NHS over the past decade. Many centres now favour sleeve gastrectomy as the primary surgical option, a trend reflected in NBSR procedure data and BOMSS guidance.

That said, for carefully selected patients, gastric banding can still achieve meaningful and sustained weight loss, along with improvements in obesity-related conditions such as type 2 diabetes, hypertension, and obstructive sleep apnoea. The evidence supports its use as part of a comprehensive programme that includes dietary support, behavioural therapy, and regular follow-up, as outlined in NICE guideline CG189 (Obesity: identification, assessment and management). Safety outcomes are strongly linked to patient adherence to post-operative guidance and ongoing clinical monitoring.

Risks, Complications and Long-Term Considerations

Key long-term risks include band slippage, erosion, port failure, and oesophageal dilation; patients should seek emergency care immediately for severe abdominal pain, inability to swallow liquids, or signs of pulmonary embolism.

As with any surgical procedure, gastric banding carries both short-term and long-term risks. Understanding these is essential for informed consent.

Short-term risks include:

• Anaesthetic complications

• Infection at the port or incision site

• Blood clots (deep vein thrombosis or pulmonary embolism)

• Nausea and vomiting in the immediate post-operative period

Longer-term complications are more specific to the device itself and include:

• Band slippage — the stomach can slip through the band, causing obstruction or reflux

• Band erosion — the band gradually wears through the stomach wall (less common but serious)

• Port or tubing problems — leaks, flips, or disconnections requiring further intervention

• Oesophageal dilation — prolonged restriction can cause the oesophagus to widen over time

• Inadequate weight loss or weight regain — particularly if dietary habits are not sustained

When to seek urgent help: Patients should call 999 or go to A&E immediately if they experience severe or acute abdominal or chest pain, inability to swallow liquids, persistent vomiting with signs of dehydration, high temperature, rapid heart rate, gastrointestinal bleeding, or symptoms suggestive of DVT or pulmonary embolism (such as a swollen or painful leg, or sudden breathlessness). For less urgent concerns — including persistent vomiting, difficulty swallowing, worsening reflux, or pain around the port site — patients should contact their GP or bariatric team promptly, as these may indicate a complication requiring assessment. NHS 111 can also provide guidance on the appropriate level of care.

Nutritional deficiencies, while less common with banding than with malabsorptive procedures such as bypass, can still occur. Deficiencies in iron, vitamin B12, folate, vitamin D, and thiamine have been reported; thiamine deficiency is of particular concern in patients experiencing prolonged vomiting. In line with BOMSS post-operative nutritional monitoring guidance, patients should have at least annual blood tests including full blood count, ferritin, B12, folate, vitamin D, urea and electrolytes, and liver function tests. Patients with persistent vomiting should be assessed for thiamine status promptly.

The MHRA monitors the safety of medical devices, including gastric bands, and issues device safety information when concerns are identified. Any suspected problems with a medical device or medicine should be reported via the MHRA Yellow Card scheme at yellowcard.mhra.gov.uk or via the Yellow Card app. Further information on risks is available on the NHS weight loss surgery pages.

Who Is Eligible for a Gastric Band on the NHS

NHS gastric band surgery is available under NICE CG189 to adults with a BMI of 40 kg/m² or above, or 35–39.9 kg/m² with a significant obesity-related condition, who have not achieved adequate weight loss through non-surgical interventions.

Eligibility for gastric band surgery on the NHS is governed primarily by NICE guideline CG189 (Obesity: identification, assessment and management, 2014, with subsequent updates). This sets out the criteria that patients must meet before being considered for any bariatric surgical intervention.

Generally, NHS-funded bariatric surgery — including gastric banding — may be considered for adults who:

• Have a BMI of 40 kg/m² or above, or a BMI of 35–39.9 kg/m² with a significant obesity-related health condition (such as type 2 diabetes or hypertension)

• Have tried and not achieved adequate weight loss through non-surgical interventions, including structured dietary programmes and lifestyle changes, typically via a tier 3 weight management service

• Are fit for surgery and general anaesthetic

• Are committed to long-term follow-up and lifestyle modification

NICE CG189 also supports earlier surgical intervention for people with a BMI of 35 or above and recent-onset type 2 diabetes, and recommends considering surgery at a BMI of 30–34.9 kg/m² in people with recent-onset type 2 diabetes where non-surgical measures have been insufficient. For people of Asian family origin, BMI thresholds are reduced by 2.5 kg/m², particularly in the context of assessing diabetes risk and eligibility for earlier intervention.

Contraindications are assessed on an individual basis by the MDT and may include unmanaged psychiatric illness, active substance misuse, inability to consent to or engage with the required follow-up, or anaesthetic risk that outweighs potential benefit. These are not absolute exclusions but require careful MDT consideration.

Access to NHS bariatric surgery varies by Integrated Care Board (ICB) area, and some regions apply more restrictive local commissioning criteria. Patients are typically referred through their GP to a specialist tier 3 weight management service before surgical assessment. The NHS website provides further guidance on who can have weight loss surgery, and BOMSS publishes referral and patient selection guidance for clinicians.

Alternatives to Gastric Bands Available in the UK

Sleeve gastrectomy is now the most commonly performed NHS bariatric procedure; non-surgical options include semaglutide (Wegovy®) under NICE TA875 and intragastric balloon therapy, with the best choice depending on individual clinical circumstances.

Given the declining use of gastric bands in NHS practice, it is important for patients to be aware of the full range of bariatric and weight management options available in the UK.

Surgical alternatives include:

• Sleeve gastrectomy — a portion of the stomach is permanently removed, reducing its capacity. This is now the most commonly performed bariatric procedure in the UK and is associated with strong long-term weight loss outcomes

• Roux-en-Y gastric bypass — the stomach is divided into a small pouch and connected directly to the small intestine, bypassing a section of the gut. It is highly effective but more complex, with a greater risk of nutritional deficiencies requiring lifelong monitoring

• One-anastomosis gastric bypass (OAGB) — a simpler variation of bypass surgery offered in selected specialist centres in the UK. Potential risks include bile reflux, and lifelong nutritional monitoring is required; patients should discuss the evidence and suitability with their surgical team

Non-surgical options include:

• GLP-1 receptor agonists such as semaglutide (Wegovy®), approved by the MHRA and recommended by NICE in technology appraisal TA875 for weight management in specific circumstances. Under TA875, semaglutide is available to eligible adults (broadly, BMI ≥35 kg/m² with at least one weight-related comorbidity, or BMI 30–34.9 kg/m² in certain circumstances) through specialist NHS weight management services, for a maximum of two years. Continuation is subject to review against stopping criteria. Patients should discuss eligibility with their GP or specialist team

• Intragastric balloon — a temporary device placed endoscopically (or, in some cases, swallowed) to reduce stomach capacity, typically for six to twelve months. Weight regain after removal is common without sustained lifestyle changes, and ongoing support is essential

• Tier 3 weight management programmes — structured, multidisciplinary programmes combining dietary advice, physical activity support, and psychological input, and the usual prerequisite pathway before surgical referral

The most appropriate option depends on individual clinical circumstances, preferences, and local service availability. A specialist bariatric team is best placed to guide this decision. Further information on types of weight loss surgery is available on the NHS website and through BOMSS procedure summaries.

Questions to Ask Your Surgical Team Before Proceeding

Patients should ask their surgical team about centre-specific complication and reoperation rates, NBSR participation, CQC registration, post-operative nutritional monitoring plans, and what to do if red-flag symptoms develop.

Before committing to gastric band surgery — or any bariatric procedure — it is important to have a thorough, open conversation with your surgical team. Informed decision-making is a cornerstone of safe surgical care, and a reputable bariatric centre will actively encourage patients to ask questions.

Consider asking the following:

• What is your centre's complication rate for gastric band surgery, and how does it compare with national NBSR data?

• How many gastric band procedures do you perform each year, and what is your reoperation or band removal rate?

• Why is a gastric band being recommended for me specifically, rather than a sleeve gastrectomy or bypass?

• Does your centre participate in the National Bariatric Surgery Registry (NBSR), and what is your CQC rating?

• What dietary and lifestyle support will I receive before and after surgery, and for how long (typically two to five years of follow-up is recommended)?

• What happens if the band needs to be removed — what are my options at that point, and what does revision surgery involve?

• How will my nutritional status be monitored long-term, and how often will I need blood tests and follow-up appointments?

• What are the signs of complications I should watch for, and who do I contact — including out of hours? For red-flag symptoms (severe pain, inability to swallow fluids, persistent vomiting, fever, or signs of a blood clot), should I call 999, attend A&E, or contact NHS 111?

• Is this procedure funded by the NHS, or if self-funding, what does the cost include and what aftercare is provided?

Patients considering private bariatric surgery should ensure the provider is registered with the Care Quality Commission (CQC) — providers can be checked via the CQC 'Find and compare services' directory — and that the surgical team holds appropriate credentials recognised by BOMSS. BOMSS also provides a 'Find a surgeon/service' resource for patients. Taking time to gather this information helps ensure that any decision made is well-informed, safe, and aligned with your individual health goals.

Frequently Asked Questions